Eugene Shenderov | sciencenewsnet.in

Breaking News

MSU researchers receive $4M NIH grant to study dementia risks

E-Cigarette Residue Exposure in Utero Shows Lasting Effects on Immune Response

Scientists discover ‘entirely unanticipated’ role of protein netrin1 in spinal cord development

What happens if the Department of Education disappears? Expert warns how it could threaten quality, student mobility and more.

Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers

NASA’s Hubble Sees Aftermath of Galaxy’s Scrape with Milky Way

MSU expert: Diseases threaten deer populations

Woods Hole Oceanographic Institution and Brazilian State of Pará sign Memorandum of Understanding in advance of COP30

New Study Highlights Urgent Need for Targeted Suicide Prevention and Mental Health Support for Sexual and Gender Diverse Youth

ETRI, Demonstration of 8-Photon Qubit Chip for Quantum Computation

15 Nov, 2024

Novel Immunotherapy Agent Safe, Shows Promise Against High-Risk Prostate Cancers

April 6, 2023 sarah JonasResearch Results

A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.